New hope for kids with rare swelling disorder
Disease control
AVAILABLE
This program provides early access to an experimental drug called sebetralstat for children aged 2-11 with hereditary angioedema (HAE). The goal is to treat sudden, painful swelling attacks as they happen. Doctors will give the medication to eligible children to see if it can qui…
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC